bet9¹ÙÍø announces Q4 FY1415 Audited Consolidated Financial Results

bet9¹ÙÍø announces the next steps in its relationship with Serum Institute - an exclusive distribution agreement for flu vaccine ‘Nasovac-S’ for India

bet9¹ÙÍø announces the launch of generic drug Sofosbuvir in India under the brand name ‘Hepcvir’

Stempeutics receives Advanced Therapy Medicinal Product (ATMP) classification from European Medicines Agency (EMA) for its novel stem cell drug “Stempeucel®â€

Stempeutics receives US process patent for its novel stem cell drug “Stempeucel®â€

bet9¹ÙÍø wins USD 188.95 million of Global Fund ARV Tender

bet9¹ÙÍø announces Q3 FY1415 Unaudited Consolidated Financial Results

bet9¹ÙÍø’s U.K. subsidiary enters into a joint venture agreement with existing partners – Cooper Pharma and The Pharmaceutical Institute (PHI)

Medicines for Malaria Venture announces collaborations with bet9¹ÙÍø and Strides

bet9¹ÙÍø announces a distribution agreement with Serum Institute of India for affordable paediatric vaccines in Europe

Subscribe to